Marcia H. Ratner, PhD, DABT
Department of Pharmacology & Experimental Therapeutics
Ph.D.: Boston University School of Medicine
Diplomate: American Board of Toxicology
Dr. Marcia Ratner earned her bachelors degree in Psychology from Boston University. While an undergraduate at BU, she also completed her pre-medical requirements, made the Dean’s list, and was a member of Psi Chi, the International Honor Society in Psychology. She went on to earn her doctoral degree in Behavioral Neuroscience from the Boston University School of Medicine where she trained in the Department of Neurology under the supervision of Drs. Robert G. Feldman and Raymon Durso. She subsequently completed a three year NIH/NIA Post-Doctoral Fellowship in the Biochemistry of Aging at the BUSM Department Pharmacology and Experimental Therapeutics under the guidance of Dr. David H. Farb. Dr. Ratner’s education and training provide her with genuine interdisciplinary translational research expertise in preclinical and clinical neuroscience. Dr. Ratner is a member of several professional medical societies that reflect upon her expertise in clinical research including the American Academy of Neurology, American Psychological Association, and the American Academy of Clinical Toxicology. She serves as a reviewer for several professional toxicology and medical journals and is registered with Publons.
Dr. Ratner is also a Diplomate of the American Board of Toxicology. She is an active member of several societies of professional toxicologists including the: Society of Toxicology, American Academy of Clinical Toxicology, and International Neurotoxicology Association. Dr. Ratner has served as a scientific advisor to the Workplace Safety Insurance Board of Ontario, Canada. Dr. Ratner’s contributions to the field of occupational and environmental neurotoxicology are recognized in the popular book ““Poisoned: How a Crime-Busting Prosecutor Turned His Medical Mystery into a Crusade for Environmental Victims“.
Dr. Ratner’s research is focused on interdisciplinary investigations looking at the effects of neurotoxicants and drugs on the progression and onset of age-related neurodegenerative diseases associated with learning and memory deficits such as Alzheimer’s disease and age-related mild cognitive impairment. She currently works with the Department Chairman, Dr. David Farb, in the Laboratory of Molecular Neurobiology where she is using basic behavioral and in vivo electrophysiological techniques in her preclinical studies of these relationships in wild type and transgenic rat models of age-related neurodegenerative disease.
As the Project Manager of the Department, Dr. Ratner oversees compliance with safety and regulatory policies. As a Board Certified Toxicologist Dr. Ratner has a strong understanding of regulatory toxicology. She also is a former member of the American Conference of Governmental Industrial Hygienists (ACGIH). In addition, she has served as a departmental representative to the Institutional Animal Care and Use Committee (IACUC). Dr. Ratner is available to provide assistance to all departmental faculty, students and research staff with their IACUC protocol submissions and associated training and compliance issues.
In addition to her research and administrative duties within the Department of Pharmacology, Dr. Ratner is also a regular lecturer in the graduate program in Behavioral Neurosciences; she is available to serve as a committee member or mentor to the doctoral students from this program. In addition she teaches an undergraduate course in Forensic Toxicology (BT 450) offered through the Biomedical Laboratory and Clinical Sciences Program which prepares students for careers in the fields of biotechnology and clinical research. Highly qualified students from this program are invited to seek internship opportunities under her supervision in the Laboratory of Molecular Neurobiology. In addition, Dr. Ratner regularly serves as a mentor to undergraduate students enrolled in Bioscience Academy. The Bioscience Academy is a BU-based federally funded program administered through Metropolitan College and the School of Medicine. One of Dr. Ratner’s former Bioscience Academy students, Zainab Mahmod, was awarded the Paul Queenan Memorial Award for academic excellence. She also serves as a grant reviewer for Psi Chi, the International Honor Society in Psychology.
Ratner MH, Kumaresan V, Farb DH: Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders. Frontiers in Endocrinology 2019 (In Press)
Rutchik J, Ratner MH. Is it Possible for Late Onset Schizophrenia to Masquerade as Manganese Psychosis? J Occup Environ Med. 2018 Feb 12. PMID: 29438152
Ratner MH, Jabre JF, Ewing WM, Abou-Donia M, Oliver LC: Amyotrophic lateral sclerosis—A case report and mechanistic review of the association with toluene and other volatile organic compounds. Amer J Ind Med, 2018; 61:251–260.
Ratner MH, Fitzgerald E. Understanding of the role of manganese in parkinsonism and Parkinson disease. Neurology. 2017; 88(4):338-339. PMID: 28031391
Ratner MH, and Jabre JF: (2016) Neurobehavioral Toxicology. In Reference Module in Neuroscience and Biobehavioral Psychology, Elsevier, ISBN 9780128093245
Ratner MH. A critical review of the interrelationships between genetics, neurotoxicant exposure, and age at onset of neurodegenerative diseases. Current Topics in Toxicology. 2016; (12):1-10. Embase PUI: L616391802
Ratner MH: Editorial: The Future Role of In vivo Electrophysiology in Preclinical Drug Discovery. EC Pharmacology and Toxicology 2016 Sept; 2(2):108-109.
Robitsek RJ*, Ratner MH*, Stewart TM, Eichenbaum HB, Farb DH: Combined Administration of Levetiracetam and Valproic Acid Attenuates Age Related Hyperactivity of CA3 Place Cells, Reduces Place Field Area, and Increases Spatial Information Content in Aged Rat Hippocampus. Hippocampus. 25(12):1541–1555. PMID: 25941121 * Drs. Ratner and Robitsek contributed equally to this work and share first authorship.
Ratner MH, Farb DH, Ozer JS, Feldman RG, Durso R: Younger Age at Onset of Sporadic Parkinson’s Disease Among Subjects Occupationally Exposed to Metals and Pesticides. Interdisciplinary Toxicology. 2014 7(3):123–133. PMID: 26109889
Farb DH, Ratner MH. Targeting the modulation of neural circuitry for the treatment of anxiety disorders. Pharmacol Rev. 2014 Oct;66(4):1002-32. PMID: 25237115.
Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008 Mar 20;245(3):194-205. PMID: 18291570.
Ratner MH, and Feldman, RG: Environmental Toxins and Parkinson’s Disease. In: Pfeiffer, R.F., and Ebadi M. (eds): Parkinson’s Disease. Boca Raton, CRC Press, Chapter 6, pp 51-62, 2005.
Ratner MH, Feldman RG, and White RF: Neurobehavioral Toxicology. In: Ramachandran V.S. (Ed); Encyclopedia of the Human Brain. New York, Elsevier Science, Vol. 3, pp 423-439, 2002.
Feldman RG, Ratner MH. The pathogenesis of neurodegenerative disease: neurotoxic mechanisms of action and genetics. Curr Opin Neurol. 1999 Dec;12(6):725-31. Review. PMID: 10676756.
Feldman RG, Ratner MH, Ptak T. Chronic toxic encephalopathy in a painter exposed to mixed solvents. Environ Health Perspect. 1999 May;107(5):417-22. PMID: 10210698
Kumaresan V, Ratner MH, Sugunan K, Downing S, Casarella A, Li N, Joyal AA, Farb DH: Regulation of Activity Dependent Synaptic Plasticity and Synaptic Expression of Glutamate Receptors by the Neurosteroid Pregnenolone Sulfate: Implications for Learning and Memory. Program/Poster No. 576.25. Presented at Society for Neuroscience Annual Meeting, Washington, D.C.: Society for Neuroscience, 2017. Online.
Stewart TM, Ratner MH, Downing SS, Farb DH: An α5GABAA receptor negative allosteric modulator increases spatial selectivity of CA1 place cells and hippocampal dependent spatial memory. Program/Poster No. 846.16/TT84 Presented at Society for Neuroscience Annual Meeting, Washington, D.C.: Society for Neuroscience, 2014. Online.
Robitsek R, Ratner MH, Stewart TM, Gallagher M, Eichenbaum H, Farb DH: Acute administration of levetiracteam and valproic acid reduces hippocampal hyperactivity and improves place cell function in aged rats. Program/Poster No. 773.03 Presented at Society for Neuroscience Annual Meeting, Washington, D.C., Society for Neuroscience, 2013. Online.
Ratner MH, Desbien SC, Pierce RC, Gibbs TT (2007) Pregnanolone hemisuccinate inhibits priming-induced reinstatement of cocaine seeking in rats. Presented at Experimental Biology Annual Meeting, Washington, D.C., 2007. Faseb Journal 21(6): A779.
Ratner MH, Desbiens S, Pierce RC, Gibbs TT, Farb DH: Pregnanolone hemisuccinate inhibits reinstatement of cocaine seeking behavior in rats. Program/Poster # 591.13/PP79. Presented at Society for Neuroscience Annual Meeting, Atlanta GA, Society for Neuroscience, 2006. Online.
To return to Laboratory of Molecular Neurobiology click here